Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCURAY INCARAY · Entity 1170 | Director | November 28, 2025 | December 02, 2025 |
| IRIDEX CORPIRIX · Entity 7882 | Director | June 13, 2025 | June 25, 2025 |
| InfuSystem Holdings, IncINFU · Entity 6163 | Director | May 12, 2026 | May 14, 2026 |
| Vicarious Surgical Inc.RBOT · Entity 8714 | Director | June 27, 2025 | August 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCURAY INC
Report date November 28, 2025 · Filed December 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 56,603 |
Reported balance
After 2025-11-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-28 · Grant · Acquired 56,603 · Balance 56,603 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: This represents a Restricted Stock Unit that vests 100% on 11/13/2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: This represents a Restricted Stock Unit that vests 100% on 11/13/2026.
IRIDEX CORP
Report date June 13, 2025 · Filed June 25, 2025 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.94 · Expires 2032-06-13 | Direct | 53,000 |
Reported balance
After 2025-06-13 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2025-06-13 · Grant · Acquired 53,000 · Balance 53,000 F1: This option was granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and is exempt pursuant to Rule16b-3. F2: All shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the Company's 2026 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and is exempt pursuant to Rule16b-3.
F2: All shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the Company's 2026 annual meeting of stockholders.
InfuSystem Holdings, Inc
Report date May 12, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.37 · Expires 2036-05-12 | Direct | 24,890 |
Reported balance
After 2026-05-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-12 · Grant · Acquired 24,890 · Balance 24,890 F1: The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027. |
| Common StockSEC Table I · non-derivative | Direct | 4,300 |
Reported balance
Holding disclosure · report date 2026-05-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,300 |
Filing footnotes · ownership attribution and instrument terms
F1: The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.
Vicarious Surgical Inc.
Report date June 27, 2025 · Filed August 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.61 · Expires 2035-06-26 | Direct | 5,335 |
Reported balance
After 2025-06-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-27 · Grant · Acquired 5,335 · Balance 5,335 F1: All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2026 Filed May 14, 2026 22:31 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 24,890 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001628280-26-035260 · wk-form4_1778797913.xml · derivative · entry 2 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,890 Underlying: Common Stock · 24,890 shares Expires 2036-05-12 F1 · derivative.exercise_date: The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 22:25 UTC | ACCURAY INC ARAY · Entity 1170 | GrantRestricted Stock Units · Derivative | 56,603 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-017515 · marketforms-71394.xml · derivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,603 Underlying: Common Stock · 56,603 shares Expires not disclosed F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: This represents a Restricted Stock Unit that vests 100% on 11/13/2026. F2 · derivative.expiration_date: This represents a Restricted Stock Unit that vests 100% on 11/13/2026. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:55 UTC | ACCURAY INC ARAY · Entity 1170 | Exercise / conversionRestricted Stock Units · Derivative | 56,603 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-017242 · marketforms-71315.xml · derivative · entry 3 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,603 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: This represents a Restricted Stock Unit that vests 100% on 11/21/2025. F3 · derivative.expiration_date: This represents a Restricted Stock Unit that vests 100% on 11/21/2025. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:55 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 22,642 | $1.05 | $23,774.10 |
DisclosureSEC source: 0001214659-25-017242 · marketforms-71315.xml · nonDerivative · entry 2 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,323 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:55 UTC | ACCURAY INC ARAY · Entity 1170 | Exercise / conversionCommon Stock | 56,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-017242 · marketforms-71315.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2025 Filed Aug 12, 2025 01:02 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantStock Option (right to buy) · Derivative | 5,335 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001213900-25-074540 · ownership.xml · derivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,335 Underlying: Class A Common Stock · 5,335 shares Expires 2035-06-26 F1 · derivative.exercise_date: All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 01:51 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock (right to buy) · Derivative | 53,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0000950170-25-087664 · ownership.xml · derivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 53,000 shares Expires 2032-06-13 F1 · security: This option granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule 16b-3. F2 · derivative.exercise_date: The shares are subject to vesting according to the following schedule: 100% of the Shares will vest each one-year anniversary of the date of grant or the Company's 2026 Annual Meeting of Stockholders. Read SEC document |
| June 13, 2025 Filed Jun 25, 2025 00:23 UTC Amendment | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock (right to buy) · Derivative | 53,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0000950170-25-089705 · ownership.xml · derivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 53,000 shares Expires 2032-06-13 F1 · security: This option was granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and is exempt pursuant to Rule16b-3. F2 · derivative.exercise_date: All shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the Company's 2026 annual meeting of stockholders. Read SEC document |
| May 16, 2025 Filed May 20, 2025 22:53 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 39,588 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026948 · wk-form4_1747781625.xml · derivative · entry 2 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,588 Underlying: Common Stock · 39,588 shares Expires 2035-05-16 F1 · derivative.exercise_date: The option, representing the right to purchase 39,588 shares of InfuSystem Holdings, Inc. common stock, vests on May 16, 2026. Read SEC document |
| April 23, 2025 Filed Apr 24, 2025 20:21 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 25,900 | $1.22 | $31,499.58 |
DisclosureSEC source: 0000950170-25-058084 · ownership.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,639 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:20 UTC | ACCURAY INC ARAY · Entity 1170 | GrantRestricted Stock Units · Derivative | 56,603 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-019899 · marketforms-67455.xml · derivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,603 Underlying: Common Stock · 56,603 shares Expires not disclosed F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: This represents a Restricted Stock Unit that vests 100% on 11/21/2025. F2 · derivative.expiration_date: This represents a Restricted Stock Unit that vests 100% on 11/21/2025. Read SEC document |
| November 09, 2024 Filed Nov 13, 2024 21:35 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 22,642 | $1.98 | $44,831.16 |
DisclosureSEC source: 0001214659-24-018865 · marketforms-67317.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,362 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 20:05 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 98,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-051732 · ownership.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,917 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:03 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 4,300 | $6.86 | $29,485.53 |
DisclosureSEC source: 0001628280-24-025024 · wk-form4_1716501828.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,300 F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 01:50 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 56,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-016010 · marketforms-63681.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,004 F1 · shares: This represents a Restricted Stock Unit that vests 100% on 11/9/2024. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 22:00 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 23,622 | $2.47 | $58,346.34 |
DisclosureSEC source: 0001214659-23-015156 · marketforms-63501.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,401 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 22:55 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 39,267 | $1.91 | $74,999.97 |
DisclosureSEC source: 0001209191-23-037562 · doc4.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,739 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 14, 2024 or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:10 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 65,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-046250 · ownership.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,956 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date. Read SEC document |
| November 30, 2022 Filed Dec 7, 2022 21:45 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 59,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-014663 · marketforms-57818.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,023 Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 22:25 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 12,474 | $2.33 | $29,064.42 |
DisclosureSEC source: 0001214659-22-014164 · marketforms-57625.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,968 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| October 18, 2022 Filed Oct 20, 2022 21:36 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 85,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-065295 · ownership.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,982 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in equal monthly installments over three years following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:41 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 27,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-037544 · doc4.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,472 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 15, 2023 or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 21:46 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock (right to buy) · Derivative | 15,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001209191-22-020313 · doc4.xml · derivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-03-17 F1 · security: This option granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule16b-3. F2 · derivative.exercise_date: The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest on April 17, 2022 and each month thereafter. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:58 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 31,185 | $4.81 | $149,999.85 |
DisclosureSEC source: 0001214659-21-012594 · marketforms-54457.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,442 F1 · shares: This represents a Restricted Stock Unit that vest 100% on 11/19/2022. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:20 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 13,453 | $5.32 | $71,569.96 |
DisclosureSEC source: 0001214659-21-012258 · marketforms-54387.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,257 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 21:15 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 33,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-20-000099 · edgardoc.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,710 F1 · shares: This represents a Restricted Stock Unit that vest 100% on 11/20/2021. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 22:06 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 19,481 | $4.40 | $85,716.40 |
DisclosureSEC source: 0001138723-20-000087 · edgardoc.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,078 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 22:49 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 48,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-19-000067 · edgardoc.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,559 F1 · kind: All of the restricted stock units vest on November 21, 2020. F2 · shares: This grant is represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of ARAY common stock. Read SEC document |
| November 30, 2018 Filed Dec 7, 2018 01:28 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 36,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-18-000126 · edgardoc.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,858 F1 · kind: All of the restricted stock units vest on November 16, 2019. F2 · shares: This grant is represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of ARAY common stock. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:10 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 8,850 | $4.46 | $39,471.00 |
DisclosureSEC source: 0001138723-18-000086 · edgardoc.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,273 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| January 31, 2018 Filed Feb 6, 2018 21:07 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 22,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-18-000008 · edgardoc.xml · nonDerivative · entry 1 HUSS BEVERLY A · CIK 0001222352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,123 F1 · kind: All of the restricted stock units vest on November 17, 2018. F2 · shares: This grant is represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of ARAY common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.